{"id":36790,"date":"2023-10-16T01:45:00","date_gmt":"2023-10-16T08:45:00","guid":{"rendered":"https:\/\/www.yardi.com\/blog\/?p=36790"},"modified":"2023-10-11T12:21:17","modified_gmt":"2023-10-11T19:21:17","slug":"the-leukemia-lymphoma-society","status":"publish","type":"post","link":"https:\/\/www.yardi.com\/blog\/the-leukemia-lymphoma-society\/","title":{"rendered":"The Leukemia & Lymphoma Society"},"content":{"rendered":"\n

Yardi is committed to supporting the community in every city where our offices are housed. Each year, the company distributes philanthropic aid<\/a> to organizations selected by its employees.<\/p>\n\n\n

\n
\"LLS<\/figure><\/div>\n\n\n

In 2022, Yardi offices supported more than 350 nonprofits worldwide. For the remainder of the year, we will bring you the stories of those organizations and insight into how they aid their communities.<\/p>\n\n\n\n

Today, we introduce The Leukemia & Lymphoma Society<\/a> (LLS), founded in 1949 in Rye Brook, New York, impacting the cancer community. LLS is the world’s largest voluntary nonprofit health organization that funds blood cancer research and provides education and patient services. Since 1949, LLS has invested nearly $1.6 billion in groundbreaking research, pioneering many of today\u2019s most innovative approaches.<\/p>\n\n\n\n

\u201cWe work tirelessly to find cures and ensure patients can access the lifesaving treatments they need. When someone experiences the fear and uncertainty of a cancer diagnosis, we provide hope, compassion, education and support,\u201d said Becca Gregory, campaign development director for LLS.<\/p>\n\n\n\n

LLS is starting a new project called The Dare to Dream Project<\/a>\u2014a new phase for the Children\u2019s Initiative. LLS recognizes kids are different, and their blood cancers must be treated differently, so they hope to change the standard of treatment and care for pediatric blood cancers. LLS has funded the first-ever pediatric AML Data Commons<\/strong>. This platform ensures consistency in global data reporting\u2014and launched the first-ever acute leukemia LLS PedAL Master Clinical Trial<\/strong>, matching patients to treatment based on their cancer\u2019s unique tumor biology.<\/p>\n\n\n\n

\u201cOur dream is to help as many children as possible get treatment for their cancer. We’re daring to improve the quality of life for every child with blood cancer, daring to dream of them thriving. And we\u2019re just getting started,\u201d exclaims Gregory!<\/p>\n\n\n\n

Funding from Yardi helps support research, education, policy and advocacy. LLS is committed to providing information, resources and support to those affected by blood cancers. Offerings include:<\/p>\n\n\n\n